Mechanosensitive ion channels as drug targets

Current Drug Targets. CNS and Neurological Disorders
Philip A GottliebF Sachs

Abstract

Mechanically sensitive ion channels (MSCs) are ubiquitous. They exist as two major types: those in specialized receptors that require fibrous proteins to transmit forces to the channel, and those in non-specialized tissues that respond to stress in the lipid bilayer. While few MSCs have been cloned, the existing structures show no sequence or structural homology--an example of convergent evolution. The physiological function of MSCs in many tissues is not known, but they probably arose from the need for cell volume regulation. Recently, a peptide called GsMTx4 was isolated from tarantula venom and is the first specific reagent for mechanosensitive channels. GsMTx4 is a approximately 4 kD peptide with a hydrophobic face opposite a positively charged face. It is active in the D and L forms, and appears non-toxic to mice. GsMTx4 has shown physiological effects on cationic MSCs in heart, smooth muscle, astrocytes, and skeletal muscle. By itself, GsMTx4 can serve as a lead compound or as a potential drug. Its availability opens clinical horizons in the diagnosis and treatment of pathologies including cardiac arrhythmia, muscular dystrophy and glioma.

Citations

Oct 6, 2006·Pflügers Archiv : European journal of physiology·O P Hamill
Aug 24, 2013·Differentiation; Research in Biological Diversity·Paul A JanmeyChristopher A McCulloch
Jul 15, 2009·Journal of Cardiovascular Pharmacology·Jonathan A StiberPaul B Rosenberg
Jul 19, 2012·Clinical Neuropharmacology·Saam SedehizadehPaul Maddison
May 13, 2006·Annual Review of Biophysics and Biomolecular Structure·Thomas J McIntosh, Sidney A Simon
Oct 24, 2006·Proceedings of the National Academy of Sciences of the United States of America·Maria A SpassovaDonald L Gill
Jun 1, 2007·Expert Opinion on Drug Discovery·Pierre Escoubas, Frank Bosmans
Jul 6, 2010·Neuroscience Letters·Philip A GottliebRobert Plunkett
Nov 8, 2006·Toxicon : Official Journal of the International Society on Toxinology·Birgit T PriestMcHardy M Smith
Sep 29, 2006·Neuromuscular Disorders : NMD·Nicholas P WhiteheadDavid G Allen
Jul 12, 2005·Current Opinion in Neurobiology·Andriy Anishkin, Ching Kung
May 1, 2007·The International Journal of Biochemistry & Cell Biology·Annette C HurstBoris Martinac
Jul 28, 2013·Biochimica Et Biophysica Acta·Boris Martinac
Jul 18, 2014·Scientific Reports·Tamsyn A HilderShin-Ho Chung
Dec 20, 2011·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Boris Martinac
Oct 14, 2014·Nature Photonics·Jonathan L ComptonVasan Venugopalan
Dec 2, 2006·Nature Reviews. Drug Discovery·Stanley Nattel, Leif Carlsson
Mar 19, 2020·Aging Cell·Gang FanMaik Gollasch
Dec 2, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Nia WedhasAshok Kumar
Sep 3, 2007·Sensors·Matthieu RaouxPatrick Delmas
Sep 19, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Kanji MatsukawaAtsushi Inomoto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.